Haemophagocytic langerha cell histiocutosis

Reading File
Finding Sources
Finding Sources
Searching PubMed

haemophagocytic lymphohistiocytosis Langerhans cell histiocytosis

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images

hemophagocytic lymphohistiocytosis bone marrow macrophage phagocytosis

This composite image consists of two panels illustrating clinical and pathological findings associated with scrub typhus and secondary hemophagocytic lymphohistiocytosis (HLH). Panel A is a clinical photograph of a child's shoulder region showing a pathognomonic eschar: a small, oval-shaped, necrotic cutaneous lesion with a dark, crusty center and minimal surrounding erythema. Panel B is a high-power light microscopy image of a bone marrow aspirate stained with Wright-Giemsa. It demonstrates hemophagocytosis, characterized by a large activated macrophage (histiocyte) containing engulfed hematopoietic elements, including nucleated red blood cells or leukocytes, within its cytoplasm. The image serves as an educational tool for identifying the primary diagnostic cutaneous sign of rickettsial infection (Orientia tsutsugamushi) alongside its potential systemic complication, hemophagocytic syndrome.

This composite image consists of two panels illustrating clinical and pathological findings associated with scrub typhus and secondary hemophagocytic lymphohistiocytosis (HLH). Panel A is a clinical photograph of a child's shoulder region showing a pathognomonic eschar: a small, oval-shaped, necrotic cutaneous lesion with a dark, crusty center and minimal surrounding erythema. Panel B is a high-power light microscopy image of a bone marrow aspirate stained with Wright-Giemsa. It demonstrates hemophagocytosis, characterized by a large activated macrophage (histiocyte) containing engulfed hematopoietic elements, including nucleated red blood cells or leukocytes, within its cytoplasm. The image serves as an educational tool for identifying the primary diagnostic cutaneous sign of rickettsial infection (Orientia tsutsugamushi) alongside its potential systemic complication, hemophagocytic syndrome.

This composite medical image consists of three panels demonstrating clinical findings in a case of severe infection and systemic complications. (A) Anterior-posterior chest X-ray showing extensive, ill-defined heterogeneous opacification and consolidation in the middle and lower zones of the right lung field, consistent with severe pneumonia. (B) High-magnification bone marrow aspirate (Wright-Giemsa stain) revealing active hemophagocytosis, characterized by a large macrophage engulfing multiple hematopoietic cells, including erythrocytes and precursors, indicative of hemophagocytic lymphohistiocytosis (HLH). (C) Peripheral blood smear (Wright-Giemsa stain) showing numerous schistocytes (fragmented red blood cells) including helmet cells and triangular forms, alongside a loss of central pallor in some cells. These findings are diagnostic of microangiopathic hemolytic anemia (MAHA) secondary to thrombotic microangiopathy (TMA). Together, these panels illustrate the progression from a primary pulmonary infection to secondary multisystem hematologic pathologies including septic shock-induced HLH and ADAMTS-13 associated TMA.

This composite medical image consists of three panels demonstrating clinical findings in a case of severe infection and systemic complications. (A) Anterior-posterior chest X-ray showing extensive, ill-defined heterogeneous opacification and consolidation in the middle and lower zones of the right lung field, consistent with severe pneumonia. (B) High-magnification bone marrow aspirate (Wright-Giemsa stain) revealing active hemophagocytosis, characterized by a large macrophage engulfing multiple hematopoietic cells, including erythrocytes and precursors, indicative of hemophagocytic lymphohistiocytosis (HLH). (C) Peripheral blood smear (Wright-Giemsa stain) showing numerous schistocytes (fragmented red blood cells) including helmet cells and triangular forms, alongside a loss of central pallor in some cells. These findings are diagnostic of microangiopathic hemolytic anemia (MAHA) secondary to thrombotic microangiopathy (TMA). Together, these panels illustrate the progression from a primary pulmonary infection to secondary multisystem hematologic pathologies including septic shock-induced HLH and ADAMTS-13 associated TMA.

A multi-panel medical figure displaying diagnostic findings for Hemophagocytic Lymphohistiocytosis (HLH). Panel A presents T1-weighted brain MRI scans with gadolinium enhancement in axial (left) and coronal (right) views, showing increased vessel enhancement in the cerebral sulci and bilateral dural thickening, indicative of an inflammatory process. Panel B contains high-power magnification (×1000) Wright-Giemsa stained bone marrow smears; arrows highlight activated macrophages exhibiting hemophagocytosis, specifically engulfing a nucleated cell (left) and platelets (right). Panel C shows sequential coronal abdominal CT scans demonstrating the progression from normal spleen size (left, day 12) to splenomegaly (right, day 18, 12.7 cm). Panel D is a clinical photograph of the torso showing diffuse petechiae. The composite illustrates the neurological, hematological, and systemic manifestations of secondary HLH, including aseptic encephalitis, cytopenias, and organomegaly.

A multi-panel medical figure displaying diagnostic findings for Hemophagocytic Lymphohistiocytosis (HLH). Panel A presents T1-weighted brain MRI scans with gadolinium enhancement in axial (left) and coronal (right) views, showing increased vessel enhancement in the cerebral sulci and bilateral dural thickening, indicative of an inflammatory process. Panel B contains high-power magnification (×1000) Wright-Giemsa stained bone marrow smears; arrows highlight activated macrophages exhibiting hemophagocytosis, specifically engulfing a nucleated cell (left) and platelets (right). Panel C shows sequential coronal abdominal CT scans demonstrating the progression from normal spleen size (left, day 12) to splenomegaly (right, day 18, 12.7 cm). Panel D is a clinical photograph of the torso showing diffuse petechiae. The composite illustrates the neurological, hematological, and systemic manifestations of secondary HLH, including aseptic encephalitis, cytopenias, and organomegaly.

Searching Images

Langerhans cell histiocytosis Birbeck granules CD1a histology

Imaging modality and technique: Transmission Electron Microscopy (TEM); ultrastructural visualization of Birbeck granules within Langerhans cells. Specimen: routine biopsy tissue containing dendritic histiocytes from a suspected Langerhans cell histiocytosis lesion. Location: cutaneous/epidermal/dermal tissue; observed in situ cytoplasmic inclusions. Features: Birbeck granules are zipper-like, pentalaminar rods with a dilated terminal end producing a tennis racket shaped appearance. These cytoplasmic organelles measure approximately 200-400 nm in length and about 33 nm in width. The dilated distal end contains langerin (CD207) and is a hallmark ultrastructural feature of Langerhans cells. Comparative context: Birbeck granules distinguish Langerhans cells from other mononuclear phagocytes on TEM; however, modern diagnostics rely on immunohistochemical markers such as CD1a and CD207 (langerin), making TEM less routinely used today. Pathological significance: the presence of Birbeck granules supports a diagnosis of Langerhans cell histiocytosis when correlated with histology and IHC. Clinical correlation: LCH may present with bone lesions, skin rash, or organ involvement; TEM was historically the gold standard but is now largely supplanted by CD1a and langerin IHC, with ultrastructural confirmation reserved for academic or unresolved cases. Educational utility: illustrates classic ultrastructure of dendritic histiocytes and their diagnostic utility in pathology. This image emphasizes ultrastructural differentiation and context for learners.

Imaging modality and technique: Transmission Electron Microscopy (TEM); ultrastructural visualization of Birbeck granules within Langerhans cells. Specimen: routine biopsy tissue containing dendritic histiocytes from a suspected Langerhans cell histiocytosis lesion. Location: cutaneous/epidermal/dermal tissue; observed in situ cytoplasmic inclusions. Features: Birbeck granules are zipper-like, pentalaminar rods with a dilated terminal end producing a tennis racket shaped appearance. These cytoplasmic organelles measure approximately 200-400 nm in length and about 33 nm in width. The dilated distal end contains langerin (CD207) and is a hallmark ultrastructural feature of Langerhans cells. Comparative context: Birbeck granules distinguish Langerhans cells from other mononuclear phagocytes on TEM; however, modern diagnostics rely on immunohistochemical markers such as CD1a and CD207 (langerin), making TEM less routinely used today. Pathological significance: the presence of Birbeck granules supports a diagnosis of Langerhans cell histiocytosis when correlated with histology and IHC. Clinical correlation: LCH may present with bone lesions, skin rash, or organ involvement; TEM was historically the gold standard but is now largely supplanted by CD1a and langerin IHC, with ultrastructural confirmation reserved for academic or unresolved cases. Educational utility: illustrates classic ultrastructure of dendritic histiocytes and their diagnostic utility in pathology. This image emphasizes ultrastructural differentiation and context for learners.

Immunohistochemistry image of pulmonary tissue stained for CD1a demonstrating Langerhans cell histiocytosis. Modality: Immunohistochemistry (IHC) using CD1a primary antibody with DAB chromogen and hematoxylin counterstain. The specimen is lung parenchyma showing a dense cluster of mononuclear dendritic cells with characteristic irregular, reniform (coffee-bean) nuclei surrounded by a background of inflammatory cells. Strong, paranuclear and cytoplasmic CD1a positivity is evident as uniform brown membrane/cytoplasmic labeling of most lesional cells. Langerin (CD207) and S-100 would be co-expressed in the Langerhans cells, though not all panels may be shown in this image. The staining pattern and cellular morphology support the diagnosis of LCH in the pulmonary setting, where Langerhans cells form focal infiltrates and can be associated with smoking-related lung disease. Birbeck granules, while historically demonstrated by electron microscopy, are now replaced by the immunophenotype. This image emphasizes diagnostic specificity of CD1a positivity for identifying Langerhans cells within the alveolar/interstitial compartment. Clinically, pulmonary LCH is frequently linked to adult smokers and may present with nodules or cystic lesions on radiology; histology for CD1a/CD207/S-100 confirms the diagnosis and guides management, including smoking cessation, surveillance, and potential targeted therapies in refractory cases. This panel is essential for diagnostic confirmation in ambiguous clinical-pathological scenarios.

Immunohistochemistry image of pulmonary tissue stained for CD1a demonstrating Langerhans cell histiocytosis. Modality: Immunohistochemistry (IHC) using CD1a primary antibody with DAB chromogen and hematoxylin counterstain. The specimen is lung parenchyma showing a dense cluster of mononuclear dendritic cells with characteristic irregular, reniform (coffee-bean) nuclei surrounded by a background of inflammatory cells. Strong, paranuclear and cytoplasmic CD1a positivity is evident as uniform brown membrane/cytoplasmic labeling of most lesional cells. Langerin (CD207) and S-100 would be co-expressed in the Langerhans cells, though not all panels may be shown in this image. The staining pattern and cellular morphology support the diagnosis of LCH in the pulmonary setting, where Langerhans cells form focal infiltrates and can be associated with smoking-related lung disease. Birbeck granules, while historically demonstrated by electron microscopy, are now replaced by the immunophenotype. This image emphasizes diagnostic specificity of CD1a positivity for identifying Langerhans cells within the alveolar/interstitial compartment. Clinically, pulmonary LCH is frequently linked to adult smokers and may present with nodules or cystic lesions on radiology; histology for CD1a/CD207/S-100 confirms the diagnosis and guides management, including smoking cessation, surveillance, and potential targeted therapies in refractory cases. This panel is essential for diagnostic confirmation in ambiguous clinical-pathological scenarios.

Transmission Electron Microscopy (TEM) image of an epidermal Langerhans cell illustrating Birbeck granules. Birbeck granules are zipper‑like, pentalaminar tubules with a dilated terminus that yields a tennis‑racket appearance; their canonical morphology is highly specific for Langerhans cells. In this specimen, the granules measure approximately 200–400 nanometers in length and about 33 nanometers in width, with a characteristic periodic, curvilinear lattice within the tubule walls. The dilated end often contains structural proteins such as langerin (CD207) and participates in antigen capture and processing. TEM historically served as a gold standard for diagnosing Langerhans cell histiocytosis (LCH) by demonstrating these ultrastructural features; however, modern diagnostic practice relies more on immunohistochemical markers (CD1a and CD207) and molecular tests, making TEM less commonly used. The surrounding cytoplasm shows abundant organelles consistent with active endocytic dendritic cells; cells may exhibit vesicular inclusions and moderate cytoplasmic granularity. This image highlights ultrastructural detail essential for educational purposes and differential diagnosis, particularly in ambiguous cases where immunophenotype is equivocal. Clinically relevant scenarios include suspected LCH in pediatric or adult patients, evaluating skin, bone, or organ involvement, and correlating ultrastructural findings with histology and flow immunophenotyping to confirm diagnosis and guide therapy planning. This image is valuable for teaching.

Transmission Electron Microscopy (TEM) image of an epidermal Langerhans cell illustrating Birbeck granules. Birbeck granules are zipper‑like, pentalaminar tubules with a dilated terminus that yields a tennis‑racket appearance; their canonical morphology is highly specific for Langerhans cells. In this specimen, the granules measure approximately 200–400 nanometers in length and about 33 nanometers in width, with a characteristic periodic, curvilinear lattice within the tubule walls. The dilated end often contains structural proteins such as langerin (CD207) and participates in antigen capture and processing. TEM historically served as a gold standard for diagnosing Langerhans cell histiocytosis (LCH) by demonstrating these ultrastructural features; however, modern diagnostic practice relies more on immunohistochemical markers (CD1a and CD207) and molecular tests, making TEM less commonly used. The surrounding cytoplasm shows abundant organelles consistent with active endocytic dendritic cells; cells may exhibit vesicular inclusions and moderate cytoplasmic granularity. This image highlights ultrastructural detail essential for educational purposes and differential diagnosis, particularly in ambiguous cases where immunophenotype is equivocal. Clinically relevant scenarios include suspected LCH in pediatric or adult patients, evaluating skin, bone, or organ involvement, and correlating ultrastructural findings with histology and flow immunophenotyping to confirm diagnosis and guide therapy planning. This image is valuable for teaching.

Loading Image
I now have everything needed for a comprehensive answer covering both conditions. Note that the user's query appears to combine two distinct entities - Haemophagocytic Lymphohistiocytosis (HLH) and Langerhans Cell Histiocytosis (LCH) - both of which are histiocytic disorders and are sometimes grouped together in teaching. I'll cover both in depth.

Histiocytic Disorders: HLH and Langerhans Cell Histiocytosis

These are two distinct - but related by lineage - disorders of the mononuclear phagocyte/dendritic cell system. Both are covered under the broader umbrella of histiocytoses.

PART 1: Haemophagocytic Lymphohistiocytosis (HLH)

Definition and Overview

HLH is a life-threatening syndrome of massive, uncontrolled hyperinflammation characterized by activation of CD8+ T lymphocytes and macrophages, leading to pathological phagocytosis of blood cells and widespread organ damage. It exists in primary (genetic) and secondary (acquired) forms. When triggered by autoimmune conditions, it is called Macrophage Activation Syndrome (MAS or MAS-HLH).
  • Harrison's 22E, p.1348

Pathophysiology

The central defect is impaired cytotoxic lymphocyte function. Normally, CD8+ T cells and NK cells kill their targets (e.g., virus-infected cells) efficiently, then disengage. In HLH:
  1. Cytotoxic lymphocytes cannot kill targets effectively (due to defects in perforin, granzyme secretion, or granule fusion machinery)
  2. They remain engaged with target cells for prolonged periods
  3. This drives excessive IFN-gamma release
  4. IFN-gamma causes unbridled macrophage activation
  5. Macrophages release toxic levels of TNF, IL-6, and other cytokines
  6. The result is a cytokine storm resembling sepsis/SIRS, with multi-organ failure
  • Robbins Basic Pathology, p.401

Classification

Primary HLH (Mendelian/Genetic):
CategoryGeneProtein
FHL2PRF1Perforin (30% of FHL cases)
FHL3UNC13DMunc13-4 (30%)
FHL4STX11Syntaxin 11 (10%)
FHL5STXBP2Munc18-2 (20%)
XLP1SH2D1ASAP adaptor protein
XLP2BIRC4/XIAPXIAP (antiapoptotic)
Griscelli syndrome type 2RAB27ASilver-colored hair + immune defects
Chediak-Higashi syndromeLYSTGiant lysosomes in leukocytes
Secondary HLH (Non-Mendelian):
  • Infection-associated: EBV (most frequent trigger), viral, bacterial, parasitic, fungal
  • Malignancy-associated: especially peripheral T-cell lymphomas
  • Autoimmune-associated (MAS-HLH): systemic JIA, adult-onset Still's disease, SLE, vasculitis
  • Transplant-associated
  • Harrison's 22E, Table 66-1

Epidemiology

  • Primary HLH (FHL): incidence ~1 in 50,000 live births; autosomal recessive; median onset 3-6 months
  • More common where consanguinity is frequent
  • Untreated, median survival is only 1-2 months
  • Secondary HLH is far more common in adults

Clinical Features

SystemFeatures
ConstitutionalFever (often high, persistent), sepsis-like state
HaematologicalThrombocytopenia (often severe), anaemia, neutropenia - bicytopenia/pancytopenia
HepaticHepatosplenomegaly, elevated transaminases, conjugated hyperbilirubinaemia, elevated GGT
CoagulationDIC, hypofibrinogenaemia, severe bleeding
CNSSeizures, decreased consciousness, meningism, cranial nerve palsies, ataxia (~1/3 at diagnosis)
SkinPetechiae, purpura, transient maculopapular rash
Lymph nodesLymphadenopathy (~50%)

Bone Marrow Findings

Macrophages actively phagocytosing red cells, platelets, and nucleated marrow cells - this is the hallmark "hemophagocytosis." However, it may be absent early in the disease, and serial bone marrow exams may be needed.
HLH bone marrow: activated macrophage engulfing hematopoietic cells (Wright-Giemsa stain)
HLH multi-panel: brain MRI, bone marrow hemophagocytosis, splenomegaly, petechiae

Laboratory Findings (HLH-2004 Diagnostic Criteria)

At least 5 of 8 criteria required:
  1. Fever
  2. Splenomegaly
  3. Cytopenias in ≥2 cell lines
  4. Hypertriglyceridaemia and/or hypofibrinogenaemia
  5. Haemophagocytosis in BM, spleen, or lymph nodes
  6. Low/absent NK cell activity
  7. Ferritin >500 ng/mL (very high >10,000 µg/L is more specific)
  8. Elevated soluble CD25 (sIL-2R)
  • Robbins Basic Pathology, p.401-402

Additional Investigations

  • Perforin expression by flow cytometry - reduced in FHL2
  • CD107a degranulation assay (assesses cytotoxic granule exocytosis) - functional screen for genetic HLH
  • Genetic testing for FHL mutations
  • CSF examination (elevated cells/protein in ~50% of FHL)
  • MRI brain (nonspecific findings)

Treatment

Induction (HLH-94/HLH-2004 Protocol):
  • Etoposide + dexamethasone for 8 weeks
  • Cyclosporine A added in HLH-2004 protocol
  • Intrathecal methotrexate for CNS involvement
Emerging/Targeted Therapy:
  • Emapalumab (anti-IFN-gamma monoclonal antibody) - approved for refractory primary HLH
  • Ruxolitinib (JAK1/2 inhibitor) - targets the IFN-gamma/JAK pathway
  • BRAF inhibitors in specific contexts
Definitive Cure:
  • Haematopoietic stem cell transplantation (HSCT) - the only curative treatment for primary HLH; must be performed after achieving remission
For MAS-HLH: IL-1 inhibitors (anakinra), IL-6 inhibitors, cyclosporine.
  • Harrison's 22E, p.137

PART 2: Langerhans Cell Histiocytosis (LCH)

Definition

LCH is an umbrella term for a group of clonal proliferative disorders of Langerhans cells (immature dendritic cells normally found in epidermis and other organs). All forms are considered variations of the same basic disorder and are now understood to be neoplastic, not reactive.
  • Robbins Basic Pathology, p.423-424

Cell of Origin and Immunophenotype

Normal Langerhans cells are immature dendritic cells that capture antigens and present them to T cells. The neoplastic cells express:
  • CD1a (key diagnostic marker)
  • Langerin (CD207) - transmembrane protein associated with Birbeck granules
  • S-100 protein
  • MHC class II antigens
Under light microscopy: abundant, often vacuolated cytoplasm with vesicular, folded/grooved nuclei ("coffee bean" nuclei) - resembling histiocytes rather than normal dendritic cells.
LCH histology (Robbins): folded/grooved nuclear contours, abundant pink cytoplasm
eFig. 10.9 from Robbins: Langerhans cell histiocytosis. Tumor cells have folded or "grooved" nuclear contours and abundant pink cytoplasm.

Ultrastructural Hallmark: Birbeck Granules

On electron microscopy: cytoplasmic pentalaminar rod-like tubular structures with characteristic periodicity and sometimes a dilated terminal end giving a "tennis racket" appearance. Modern diagnosis primarily uses CD1a/CD207 immunohistochemistry; EM is now reserved for uncertain cases.
Birbeck granules on TEM - tennis racket appearance, ~200-400 nm, pathognomonic for Langerhans cells
CD1a IHC in pulmonary LCH showing brown cytoplasmic/membranous staining of lesional cells

BRAF Mutation - Key Molecular Pathogenesis

A major advance: most LCH cases harbor a BRAF V600E mutation, activating the RAS-MAPK pathway and driving cellular proliferation and survival. This same mutation occurs in hairy cell leukemia, melanoma, papillary thyroid carcinoma, and colon cancer. BRAF inhibitors (vemurafenib, dabrafenib) are now effective targeted therapies for refractory LCH.
  • Robbins Basic Pathology, p.424-425

Clinical Forms

LCH exists on a spectrum from indolent to aggressive:

1. Multisystem LCH (Letterer-Siwe Disease) - Most Aggressive

  • Children <2 years of age
  • Multifocal cutaneous lesions resembling seborrheic dermatitis
  • Hepatosplenomegaly, lymphadenopathy
  • Pulmonary lesions
  • Destructive osteolytic bone lesions (late course)
  • Bone marrow infiltration → pancytopenia → recurrent bacterial infections
  • Rapidly fatal if untreated; with intensive chemotherapy, ~50% survive 5 years

2. Unisystem LCH (Eosinophilic Granuloma) - Least Aggressive

  • Unifocal or multifocal
  • Expanding accumulations in medullary cavities of bones (most common: calvaria, ribs, femur)
  • Langerhans cells admixed with eosinophils, lymphocytes, plasma cells, neutrophils
  • Unifocal: often asymptomatic or causes bone pain; may heal spontaneously or be cured by local excision/irradiation
  • Multifocal unisystem disease: multiple erosive bony masses; ~50% have involvement of the posterior pituitary stalkdiabetes insipidus
  • Classic triad: Hand-Schuller-Christian triad = calvarial bone defects + diabetes insipidus + exophthalmos

Summary Comparison

FeatureHLHLCH
Cell typeMacrophages (activated)Langerhans cells (dendritic cell lineage)
NatureReactive hyperinflammation (primary: genetic; secondary: acquired)Clonal neoplastic proliferation
MarkerHaemophagocytosis on BM biopsyCD1a, CD207, S-100; Birbeck granules
Key mutationPRF1, UNC13D, STX11, STXBP2 (primary)BRAF V600E
AgePrimary: infants; Secondary: any ageLetterer-Siwe: <2 yrs; eosinophilic granuloma: older children/adults
CytokineIFN-gamma driven cytokine stormRAS-MAPK proliferation signal
Key labFerritin >10,000, sIL-2R, hypertriglyceridaemiaBone lytic lesions, diabetes insipidus
TreatmentEtoposide + dexamethasone → HSCTObservation, excision, chemo, BRAF inhibitors
PrognosisRapidly fatal if untreated (primary)Variable: unifocal (excellent) to Letterer-Siwe (poor)

Relationship Between HLH and LCH

Both belong to the histiocytosis family - disorders of the mononuclear phagocyte/dendritic cell lineage. The 2016 revised Emile classification groups histiocytoses into 5 groups: L-group (LCH, Erdheim-Chester), C-group (non-LCH cutaneous), M-group (malignant histiocytoses), R-group (Rosai-Dorfman), and H-group (HLH/MAS). Importantly, LCH can trigger secondary HLH in rare cases - a clinically important overlap.

Sources:
This is a shared conversation. Sign in to Orris to start your own chat.